GulfBase Live Support
Leave a message and our representative will contact you soon
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
| Ticker | Price | Volume |
|---|
09/04/2026
Zain Bahrain, a leading provider of telecom services, innovative technologies and digital lifestyle experience in the kingdom, has appointed Ammar Al Ketbi as its new Chief Executive Officer.
Trade Arabia
09/04/2026
Al Mal Capital , a UAE based investment management and financial advisory firm, licensed by the Capital Markets Authority (CMA) has appointed Sanjay Vig as the Chief Executive Officer.
Vig
Trade Arabia
09/04/2026
Abu Dhabi Maritime Academy (ADMA), the region's leading academic institution for maritime training, and an integral part of AD Ports Group, has signed a research, development, and operational deploym
Trade Arabia
09/04/2026
Saudi-based Alkhorayef Water and Power Technologies Company has announced that it has secured a SAR69.5 million ($18.5 million) sewage project works contract from Royal Commission for Riyadh City.
Trade Arabia
09/04/2026
Saudi-based Asas Makeen Real Estate Development and Investment Company has announced that it has signed an agreement with Tawafuq Al Rimal Real Estate Fund for the development of an integrated reside
Trade Arabia